Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development
Arthritis & Rheumatology · 2025-09 · 77 (9) · 1166-1178
DOI: 10.1002/art.43175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 13.05.2025. Verfasst von Samir Rachid Zaim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Allen Institute for Immunology, Seattle, Washington. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Anti-Citrullinated Protein Antibodies, Autoantibodies. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: NIAMS NIH HHS, Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Objective
This longitudinal case‐control study evaluated serum proteomics before a clinical diagnosis of rheumatoid arthritis (RA) (ie, pre‐RA) to evaluate biologic pathways of disease development and inform prediction of timing of onset of future disease.
Methods
Patients (n = 213) meeting the 1987 American College of Rheumatology classification criteria for RA and matched controls without RA (n = 215) were identified in the Department of Defense Serum Repository. Serum samples from patients before and after RA diagnosis and controls were tested for RA‐related autoantibodies (anti–cyclic citrullinated peptide‐3 [anti‐CCP3] and rheumatoid factor [RF] isotypes IgM and IgA) and 197 proteins using a commercial platform (Olink). We applied linear mixed effect models to identify biomarkers distinguishing patients from controls before RA diagnosis and analyzed longitudinal patterns of enriched pathways; in addition, models were developed to classify the time of a sample in relationship to the time of RA diagnosis.
Results
Levels of anti‐CCP3, RFIgA, and RFIgM demonstrated the greatest differences between patients and controls ≤5 years before RA diagnosis. Longitudinal analyses identified 104 proteins that were differentially expressed between patients and controls; 60 proteins were differentially expressed ≤5 years before diagnosis, 42 proteins were differentially expressed within and before five years of diagnosis, and 2 proteins were differentially expressed >5 years before diagnosis. Kyoto Encyclopedia of Genes and Genomes analyses identified that these proteins were associated with 32 pathways, including 21 pathways that were enriched ≤5 years before diagnosis. Within the anti–citrullinated protein antibody–positive samples from before RA diagnosis and controls, a set of features classified if that sample was from a period
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Allen Institute for Immunology, Seattle, Washington.
- Inova Diagnostics, San Diego, California.
- University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
- University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
ORCID-Profile: Samir Rachid Zaim, Adam K Savage, Lynne A Becker, Ted R Mikuls, Kevin D Deane
Förderung
- NIAMS NIH HHS
- Congressionally Directed Medical Research Programs
Zitieren
APA
Rachid Zaim, S., Savage, A. K., Gillespie, M. A., Castillo, J. D., Bennett, C., Torgerson, T. R., Becker, L. A., Mahler, M., Moss, L., Feser, M. L., Edison, J. D., Mikuls, T. R., Holers, V. M., Li, X. J., & Deane, K. D. (2025). Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development. Arthritis & Rheumatology, 77(9), 1166-1178. https://doi.org/10.1002/art.43175
Vancouver
Rachid Zaim S, Savage AK, Gillespie MA, Castillo JD, Bennett C, Torgerson TR, et al. Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development. Arthritis & Rheumatology. 2025;77(9):1166-1178. doi:10.1002/art.43175
BibTeX
@article{RachidZaim2025,
author = {Rachid Zaim, Samir and Savage, Adam K and Gillespie, Mark A and Castillo, Jazmine D and Bennett, Christy and Torgerson, Troy R and Becker, Lynne A and Mahler, Michael and Moss, LauraKay and Feser, Marie L and Edison, Jess D and Mikuls, Ted R and Holers, V Michael and Li, Xiao-Jun and Deane, Kevin D},
title = {Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development},
journal = {Arthritis & Rheumatology},
year = {2025},
volume = {77},
number = {9},
pages = {1166--1178},
doi = {10.1002/art.43175}
}
EUVIMED